Global Non-invasive Blood Glucose Monitoring Devices Market
Non-invasive glucose monitoring is pivotal for the improvement of diabetes management, as it provides enhanced, pain-free blood glucose assessment. This therefore leads to the expansion of the global non-invasive blood glucose monitoring devices market. These devices measure blood glucose levels in diabetic patients, without puncturing the skin, or causing any pain or trauma. The frequent change in blood glucose levels in diabetic patients has to be tracked with the help of glucose monitoring devices. Glucose monitoring devices can be invasive and non-invasive as well. However, the non-invasive blood glucose monitoring devices market is gaining major traction due to the need of economic, compact, painless, and convenient devices for patients to use.
Market Insights
The global non-invasive blood glucose monitoring devices market was pegged at US$ 5.1 million in 2017, and is expected to witness a CAGR of 35.0% over the forecast period (2018-2026).
Request Sample Copy of Report: https://www.coherentmarketinsights.com/insight/request-sample/1480
Convenience offered by non-invasive blood glucose monitoring devices over self-monitoring devices is expected to drive the non-invasive blood glucose monitoring devices market growth in the near future. The non-invasive blood glucose monitoring systems require less number of finger sticks and enable easy transfer and sharing of data from the devices for further analysis. For instance, DiaMonTech GmbH, a Germany-based medical device company has developed a non-invasive glucose monitoring device: DMT Pocket; which non-invasively measures the blood glucose without drawing blood, finger pricking, or a test strip. It measures the blood glucose level simply by relaxing patient’s fingertip on the sensor, and displays the blood glucose levels in 5 to 15 seconds. This device can also communicate with mobile phone, enabling easy access to the information at any time.
Market Growth Restraints
Non-invasive blood glucose monitoring devices are the next step in continuous glucose monitoring (CGM) devices due to various reasons related to the wearer’s comfort. These non-invasive glucose monitoring devices are based on technology, which detects characterization of the biological properties of the skin or biological fluids such as saliva or tears that can be used to track glucose changes in strictly controlled conditions.
However, none of these devices provides pin-point accuracy, close to that of the minimally invasive CGM devices, under uncontrolled conditions. This is mainly due to the reason that minimally invasive CGM devices measure glucose concentration subcutaneously with an enzymatic sensor that is in contact with biological fluids containing glucose molecules, whereas non-invasive CGM devices measure skin characteristics modulated by glucose changes that are also sensitive to intrinsic (physiology related) and extrinsic (environment related) factors.
Get PDF Broacher Here: https://www.coherentmarketinsights.com/insight/request-pdf/1480
Global Non-invasive Blood Glucose Monitoring Devices Market – Regional Insights
North America is expected to be the most lucrative region in the non-invasive blood glucose monitoring devices market over the forecast period due to factors such as increasing engagement of government healthcare regulatory bodies in promoting intermittent or continuous glucose monitoring among diabetic people. Increasing incidence of diabetes and risk factors associated with it such as binge eating, sedentary lifestyle, and insulin resistance, among others in this region, and higher number of non-invasive glucose monitoring devices currently in the development phase, which are expected to launch in the near future.
In the Asia Pacific region, the non-invasive blood glucose monitoring devices market size is expected to witness rapid growth, owing to the evolving healthcare infrastructure, particularly in the emerging economies of India, and rising incidence of diabetes in the region. As per the Asian Diabetes Prevention Initiative, around 113.9 million adults have diabetes in China and 65.1 million adults were diagnosed with diabetes in India in 2013. In addition, China and India are estimated to account for over half a billion of the global diabetic population by 2030.
Competitive Landscape
The key players operating in the global non-invasive blood glucose monitoring devices market include DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
Direct Purchase this Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1480
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837